Kamal Therapeutics
Hingham, US · Founded 2020 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MD
Mark de SouzaExecutive Officer, Director
PR
Philip ReillyDirector
JP
John ParkerDirector
AS
Alexander SilverDirector
HL
Hal LandyDirector
JM
Joff MasukawaDirector
DR
Deborah RamsdellExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$13.8MraisedNov 2025 · 41 investors · PharmaceuticalsRule 506(b)
▶$13.8MraisedNov 2025 · 41 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark de SouzaExecutive Officer, Director
- Philip ReillyDirector
- John ParkerDirector
- Offering amount
- $17.3M
- Amount sold
- $13.8M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$9.9MraisedOct 2022 · 37 investors · PharmaceuticalsRule 506(b)
▶$9.9MraisedOct 2022 · 37 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alexander SilverDirector
- Hal LandyDirector
- Joff MasukawaDirector
- Deborah RamsdellExecutive Officer, Director
- Mark P. de SouzaDirector
- Offering amount
- $10M
- Amount sold
- $9.9M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.